Description
Rejuran is a gel formation of polynucleotide that has been approved by the Korean FDA. It is created using salmon sperm DNA fragments, molecules that are free of side-effects and have been proven to induce long-term tissue regeneration from within the deep dermis.
As the new concept of skin healing filler using Polynucleotide (PN) which is a tissue regeneration material, Rejuran Healer helps skin maintain healthy and beautiful by improving the physiological condition of damaged inner skin.
Rejuran is referred to as a “Healer” rather than regular filler, it gradually improve the general biological condition of damaged skin as well as regenerate new cells to keep your skin young and healthy. This is something that other fillers cannot do. This injection is recommended as an anti-aging and the result is comparable with placenta & stem cell.
HOW ‘REJURAN HEALER’ WORKS
REJURAN HEALEAR delievers nucleotides, which serve as the monomers, or subunits, of nucleic acids like DNA and RNA. This action mechanism worked for human dermis and proved that it repairrs damaged dermi cells and keeps them healthier. In 3~5 days from the initial injection, you will feel more silky texture from your facial skin and then witness enhanced turgidity after 2~4 weeks.
BENEFITS OF ‘REJURAN HEALER ‘
Safe and simple injection
Protecting wrinkles
Skin lifting effect
Skin brightening
Improving elasticity, turgidity and tonicity of skin
Repairing damaged dermal cells
High physical compatiability of Polynucleotide extracted from salmon
TRIPLE EFFECT WITH REJURAN HEALRE, SKIN BOTOX, & HYALURONIC ACID INJ.
Korea Medical Hub has the only right to offer this special skin healing package to our customers.
Not only the REJURAN HEALER but two other injections will be provided for women who would like to see a prompt reaction with the quick procedures ever.
REJURAN HEALER: fundamentally repairing damged dermis cells
SKIN BOTOX: removing even tiny wrinkles
HYALURONIC ACID: keeping dermis moisturized for longer time.
Reviews
There are no reviews yet.